-
1دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103038.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038Test -
2دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103053.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103053Test -
3دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103044.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103044Test -
4دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103056.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056Test -
5دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103041.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103041Test -
6دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103035.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_5_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103035Test -
7دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103062.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103062Test -
8دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103059.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103059Test -
9دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103050.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Methods_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103050Test -
10دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103047.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103047Test